🎙️ CPT 31540 — Laryngoscopy, Direct, Operative, With Excision Of Tumor And/Or Stripping Of Vocal Cords Or Epiglottis
Quick Reference
wRVU: 4.02 | Global Period: 090 | Assistant Payable: No | Bilateral Indicator: 2 Rule: Bilateral Indicator 2 means the published wRVU is already priced to reflect bilateral laryngeal access; appending modifier -50 will not yield a 150% payment adjustment as it would for a Bilateral Indicator 1 code. The 90-day global period encompasses all related postoperative care, and separately billed laryngoscopy services within that window will deny without a supporting modifier such as -58, -78, or -79. Modifiers -LT and -RT are appropriate when only one vocal cord or one lateralized epiglottic lesion is treated and laterality is unambiguously documented in the operative report. PC/TC split does not apply since 31540 is a fully global surgical service with no separately reportable professional or technical component.
📋 Clinical Description
CPT 31540 describes a direct operative laryngoscopy in which the surgeon excises a discrete laryngeal tumor and/or strips the mucosal epithelium of the vocal cords or epiglottis under general anesthesia using a rigid suspension laryngoscope without an operating microscope or telescope. The code encompasses cold-steel microlaryngeal forceps, cupped elevator-based stripping, and laser-assisted ablation, as no distinct CPT exists for rigid direct laryngoscopy using a laser; the key requirement is that optical magnification via a microscope or telescope is absent—if any such device is used, the procedure must be reported as 31541 instead. Lesion types most commonly addressed under this code include squamous cell carcinoma in situ, early T1 glottic carcinoma accessible without cordectomy, leukoplakia with dysplasia or hyperkeratosis, polypoid corditis (Reinke’s edema), and discrete benign tumors such as fibroepithelial polyps and retention cysts classified under J38.1 or D14.1.
Vocal cord stripping specifically refers to intentional removal of the superficial mucosal epithelium of the true vocal fold, a technique applied when epithelial dysplasia or D02.0 is present and complete eradication of the abnormal cord surface is required without deeper submucosal dissection. Epiglottic lesion excision, while less frequently performed, is also captured within this code descriptor when the epiglottis is the operative site, as its supraglottic position is fully accessible via the same transoral rigid laryngoscope approach used for glottic procedures. Unlike 31535, which is limited to diagnostic or staging biopsy of laryngeal tissue, CPT 31540 involves therapeutic removal of an entire target lesion or the full involved cord surface and therefore represents a substantially higher level of surgical complexity; the critical documentation distinction is that the intent must be therapeutic resection rather than specimen acquisition alone. Laser-assisted excision that yields a retrievable specimen or results in complete lesion ablation is appropriately captured by 31540 since the CPT code family for rigid direct laryngoscopy does not contain a separate laser-specific code, as confirmed by AMA guidance.^1^
This procedure may be performed in the following clinical contexts:
- Glottic leukoplakia with dysplasia or carcinoma in situ — When prior biopsy under 31535 confirms high-grade squamous dysplasia or D02.0, vocal cord stripping is performed to ablate the involved epithelium and obtain definitive pathologic assessment of margin status; residual or recurrent dysplasia may require repeat stripping within the 90-day global period, which must be reported with modifier -58 (staged procedure) or claims will be denied as global-period duplicates.
- T1a glottic squamous cell carcinoma — Early-stage glottic carcinoma limited to one vocal cord (C32.0) may be managed with direct laryngoscopic excision as a voice-sparing alternative to external-beam radiation; operative documentation must specify the extent of resection, margin status, and laterality to support accurate CPT and ICD-10-CM coding.
- Benign laryngeal tumor excision — Discrete benign tumors including fibroepithelial polyps, papillomas, retention cysts, hemangiomas, and other lesions classified as D14.1 are excised endoscopically under 31540 with expectation of cure; recurrent respiratory papillomatosis (RRP) is a well-established indication in which multiple papillomas are debulked at each session under a single 31540 code regardless of lesion count.
- Polypoid corditis (Reinke’s edema) — Bilateral subepithelial gelatinous accumulation within the superficial lamina propria causing fusiform polypoid swelling, classified under J38.3, is treated by incising the cord epithelium and evacuating the edematous contents, a technique functionally captured under the stripping descriptor of 31540 when complete mucosal resurfacing is performed; bilateral treatment is common and is reported with modifier -50 under awareness that Bilateral Indicator 2 limits reimbursement to 100%.
- Epiglottic lesion excision — Papillomas, mucous retention cysts, early supraglottic carcinomas (C32.1), or other accessible epiglottic pathology that does not require open or robotic surgical resection can be excised under 31540 using the supraglottic exposure of the rigid direct laryngoscope; if the extent of epiglottic resection approximates a partial epiglottectomy, the coder should review the operative note carefully to confirm 31540 remains the appropriate code versus a more complex laryngoplasty code.
🔬 Anatomical & Procedural Considerations
| Variant | Mechanism | Key Notes |
|---|---|---|
| Vocal Cord Stripping | The superficial mucosal epithelium and the underlying superficial layer of the lamina propria (Reinke’s space) are removed using a microlaryngeal cup forceps, mucosal elevator, or cold scissors with the patient in suspension laryngoscopy position under general anesthesia. Stripping proceeds from posterior to anterior along the cord, with the vocalis muscle and vocal ligament preserved where possible to maintain postoperative voice quality. The stripped specimen is submitted en face as a strip biopsy for serial histopathologic sectioning to evaluate the depth and extent of dysplasia. | Bilateral stripping is frequently performed in a single session for bilateral leukoplakia or Reinke’s edema; Bilateral Indicator 2 means payment will not exceed 100% of the single-code fee schedule even with modifier -50 appended. The operative report should separately document each cord’s extent of involvement, technique used, and hemostasis method. Postoperative stroboscopy is often recommended to assess mucosal wave dynamics but is not separately billable on the same date as the operative procedure under most payer policies. |
| Discrete Laryngeal Tumor Excision | A laryngeal mass—whether benign (polyp, papilloma, fibroma) or early malignant (Tis/T1 glottic SCC, neoplasm of uncertain behavior coded as D38.0)—is resected using cold microlaryngeal instruments or contact/CO₂ laser with the suspension laryngoscope providing the operative field without optical magnification. Adequate circumferential margins around the lesion are confirmed visually; positive or close margins prompt a second-look procedure under modifier -58 if planned within the 90-day global. The approach uses the natural oral cavity and laryngoscope as the access route, with no external incision and no wound closure. | Documentation must specify whether the procedure constitutes excision of a discrete lesion (distinct surgical margins) versus en-face mucosal stripping, as this distinction supports correct CPT selection and affects pathology billing (e.g., 88302 vs. 88304). For recurrent respiratory papillomatosis (RRP), all papillomas debulked at one session are captured under a single 31540 regardless of lesion count; separately coding each papilloma is incorrect. Laser use that yields complete ablation without a retrievable tissue specimen is still appropriately coded to 31540 per AMA guidance, as no rigid direct laryngoscopy laser code exists in the CPT series. |
| Epiglottic Lesion Excision | The epiglottis, a leaf-shaped fibrocartilaginous structure covered by stratified squamous epithelium on its lingual surface and pseudostratified columnar epithelium on its laryngeal surface, is accessed via the rigid direct laryngoscope positioned to expose the supraglottic larynx under direct vision. Epiglottic cysts, papillomas, or early carcinomas accessible without splitting the epiglottis are resected by grasping the lesion base with cup forceps and sharply excising, with hemostasis achieved by bipolar cautery or topical epinephrine. Adequate visualization is essential, as inadvertent injury to the epiglottic cartilage can result in perichondritis and subsequent supraglottic stenosis requiring further intervention. | CPT 31540 covers epiglottic tumor excision as long as the approach is direct laryngoscopy and the resection does not constitute a formal partial or total epiglottectomy; if the operative note documents epiglottis transection or resection of a substantial portion of the structure, a more complex laryngoplasty CPT in the 31580-31590 range may be more appropriate and the operative report should be queried. ICD-10-CM diagnosis coding for epiglottic lesions should specify the lesion type and subsite (e.g., C32.1 for supraglottic carcinoma involving the epiglottis) rather than defaulting to a non-specific code when documentation supports a more specific assignment. |
Clinical Pearl
Vocal cord stripping and discrete tumor excision are combined under a single CPT code—31540—regardless of whether both interventions are performed at the same session on different cords. Do not unbundle by reporting separate CPT codes for each vocal cord intervention performed during the same encounter when both fall within the scope of direct operative laryngoscopy. If an operating microscope or telescope is used for any portion of the procedure, the correct code for the entire encounter is 31541, not 31540; partial microscope use does not permit a split between codes. Laser ablation that does not yield a retrievable specimen is also correctly reported as 31540 for rigid direct laryngoscopy since no rigid-scope laser-specific code exists in this CPT range.^1^
✅ Procedure Includes
- Placement and positioning of the suspension laryngoscope — Securing the rigid laryngoscope to a chest support or suspension arm to allow bimanual instrument use within the operative field is integral to the procedure and is not separately reportable as a setup service.
- Intraoperative laryngeal visualization and lesion assessment — Complete direct visualization of the glottis, supraglottis, and accessible subglottis with documentation of lesion extent, cord mobility, and margin appearance is included in the global service; diagnostic stroboscopy or imaging requested separately on the same day is subject to payer-specific bundling review.
- Excision and/or stripping of the target lesion(s) — All instrument passes required to achieve adequate resection or epithelial stripping of the described laryngeal pathology are included; multiple passes over the same anatomic site in a single session are not separately reportable even when repeated for completeness.
- Intraoperative hemostasis — All bleeding control measures within the laryngoscope field, including bipolar electrocautery, topical epinephrine application, and mechanical compression, are integral to the procedure and may not be separately billed.
- Specimen procurement, orientation, and labeling — Collection and handoff of tissue specimens for pathologic analysis is part of the surgical service; the pathology examination itself (e.g., 88302, 88304) is separately billable by the interpreting pathologist and is not included in 31540.
- Laryngoscope removal and field inspection — Final assessment of the operative site, confirmation of hemostasis, and removal of the suspension device prior to extubation are included in the global surgical package.
- Intraoperative use of laser without a separate laser-specific CPT — When a CO₂ or KTP laser is used through the direct rigid laryngoscope for excision or ablation, no separate laser code is reportable; 31540 captures the complete service per AMA guidance.^1^
❌ Excludes / Do Not Report Together
| Code | Description | Relationship |
|---|---|---|
| 31541 | Laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis; with operating microscope or telescope | Mutually exclusive with 31540; if any optical magnification device is used during the encounter, the correct and only code is 31541 — both codes may not be reported together for the same encounter under any modifier combination. |
| 31535 | Laryngoscopy, direct, operative, with biopsy | When 31540 (therapeutic excision) is performed, any biopsy at the same anatomic site is integral to the excision and should not be separately reported; if a biopsy is obtained from a clearly distinct anatomic site not included in the excision (e.g., contralateral cord or subglottis), separate reporting with modifier -59 may be appropriate only when documentation unambiguously supports a distinct and independently indicated service. |
| 31536 | Laryngoscopy, direct, operative, with biopsy; with operating microscope or telescope | Same bundling logic applies as with 31535; biopsy at the same site is included within the excision service regardless of instrumentation, and if a microscope was used for the excision, the entire procedure should have been coded as 31541 rather than 31540. |
| 31526 | Laryngoscopy, direct, diagnostic; with operating microscope or telescope | Diagnostic laryngoscopy is bundled into operative laryngoscopy under NCCI edits; routine intraoperative visualization performed in preparation for and during 31540 is not separately reportable by the same provider on the same date, as direct assessment of the lesion is integral to the operative service. |
Bundling Alert
CPT 31540 is subject to NCCI Procedure-to-Procedure (PTP) edits that bundle diagnostic laryngoscopy codes (including 31505, 31525, and 31526) into operative laryngoscopy when performed at the same operative session by the same provider; reporting a separate diagnostic scope on the same date as 31540 requires documentation of a clearly distinct, separately medically necessary evaluation performed outside the operative encounter with its own independent note. The 90-day global period for 31540 means that post-operative laryngoscopic evaluations for wound inspection, recurrence surveillance, or voice rehabilitation assessment within that window are considered part of the global surgical package and must not be separately billed without a supporting modifier; Medicare, Wisconsin Medicaid, BCBS of WI, and UHC actively flag global-period claim patterns for 31540, and documentation of each postoperative visit must clearly distinguish whether the visit is related to the original surgical condition or meets criteria for a separately billable service under modifiers -24, -58, -78, or -79.
🌳 Code Tree — Surgery: Respiratory System, Endoscopy — Larynx
31500-31899 Surgery: Respiratory System — Larynx
│
├── 31520-31529 Diagnostic Laryngoscopy
│ ├── 31520 Laryngoscopy, direct, diagnostic, newborn (Global: 000)
│ ├── 31525 Laryngoscopy, direct, diagnostic (Global: 000)
│ └── 31526 Laryngoscopy, direct, diagnostic; with operating microscope or telescope (Global: 000)
│
├── 31530-31571 Direct Operative Laryngoscopy
│ ├── 31530 Laryngoscopy, direct, operative, with foreign body removal (Global: 090)
│ ├── 31531 Laryngoscopy, direct, operative, with foreign body removal; with operating microscope or telescope (Global: 090)
│ ├── 31535 Laryngoscopy, direct, operative, with biopsy (Global: 090)
│ ├── 31536 Laryngoscopy, direct, operative, with biopsy; with operating microscope or telescope (Global: 090)
│ ├── ▶▶ 31540 ◀◀ Laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis ← YOU ARE HERE (Global: 090)
│ ├── 31541 Laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis; with operating microscope or telescope (Global: 090)
│ ├── 31545 Laryngoscopy, direct, operative, with operating microscope or telescope, with submucosal removal of non-neoplastic lesion(s) of vocal cord; reconstruction with local tissue flap(s) (Global: 090)
│ ├── 31546 Laryngoscopy, direct, operative, with operating microscope or telescope, with submucosal removal of non-neoplastic lesion(s) of vocal cord; reconstruction with graft(s) (includes obtaining autograft) (Global: 090)
│ ├── 31570 Laryngoscopy, direct, with injection into vocal cord(s), therapeutic (Global: 090)
│ └── 31571 Laryngoscopy, direct, with injection into vocal cord(s), therapeutic; with operating microscope or telescope (Global: 090)
│
└── 31575-31579 Flexible Laryngoscopy
├── 31575 Laryngoscopy, flexible; diagnostic (separate procedure) (Global: 000)
└── 31576 Laryngoscopy, flexible; with biopsy(ies) (Global: 090)
💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU | 4.02 |
| Global Period | 090 (90-day global) |
| Bilateral Indicator | 2 (RVU already reflects bilateral laryngeal scope; -50 does not yield 150% adjustment) |
| Assistant Surgeon | No (not payable by Medicare for this code) |
| Co-Surgeon | No |
| Team Surgery | No |
| PC/TC Split | Not applicable (global surgical service only; no indicator) |
| Modifier -51 Exempt | No |
| Anesthesia | Separate anesthesia CPT applicable; general anesthesia is required for direct operative laryngoscopy and is billed separately by the anesthesia provider |
Bilateral Billing Rules
Bilateral Indicator 2 for CPT 31540 means the published wRVU of 4.02 is already set to reflect the scope of a bilateral laryngeal procedure; appending modifier -50 will not result in a 150% payment adjustment as it would for a Bilateral Indicator 1 code, and reimbursement is capped at 100% of the single-code fee schedule amount. When both vocal cords are stripped or excised in one operative session and the operative report clearly documents bilateral treatment, report 31540 once with modifier -50 to reflect the bilateral nature without expecting a payment uplift. If treatment is definitively limited to a single cord and laterality is clearly documented, modifiers -LT or -RT are preferred over -50, as they more accurately reflect unilateral scope and preserve the ability to bill the contralateral cord at full value in a subsequent encounter outside the global period. Verify bilateral billing policies individually with Wisconsin Medicaid, BCBS of WI, UMR, UHC, Cigna, and Aetna replacement plans, as state Medicaid and commercial payers may apply bilateral rules that differ from Medicare’s Bilateral Indicator 2 assignment.^2^
🏷️ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -LT | Left Side | Apply when the procedure is performed exclusively on the left vocal cord or a left-sided laryngeal or epiglottic lesion; the operative report must specify the left cord as the operative site and confirm no intervention on the right cord. |
| -RT | Right Side | Apply when the procedure is limited to the right vocal cord or a right-sided laryngeal lesion; particularly important when only one cord bears pathology and the contralateral cord is explicitly documented as normal and untreated. |
| -50 | Bilateral | Append when excision or stripping is performed on both vocal cords in a single operative session; due to Bilateral Indicator 2, payment under Medicare and most payers will not exceed 100% of the single fee schedule amount, and the bilateral nature must be unambiguously supported by the operative report. |
| -24 | Unrelated E/M During Postoperative Period | Apply when an E/M service is provided during the 90-day global period for a condition clearly unrelated to the laryngeal procedure; the E/M note must explicitly identify the unrelated condition and must not reference surgical follow-up, wound care, or the original operative indication. |
| -25 | Significant, Separately Identifiable E/M Service | Use on the same date as 31540 when a separately identifiable and independently documented E/M service was provided for a distinct condition; the E/M must contain its own history, examination, and medical decision-making elements beyond the pre-procedure assessment and must address a separate clinical indication. |
| -51 | Multiple Procedures | Report when 31540 is performed on the same date as other non-exempt surgical procedures; reimbursement for the secondary procedure(s) will typically be reduced to 50% by Medicare and most commercial payers per MPFS multiple procedure payment reduction rules. |
| -52 | Reduced Services | Apply when the planned laryngoscopic excision or stripping was only partially completed due to anatomic limitation, equipment failure, or patient intolerance after anesthesia was administered; the specific reason for reduction must be documented in the operative report. |
| -53 | Discontinued Procedure | Use when the operative laryngoscopy was initiated after anesthesia induction but abandoned entirely due to patient safety concerns before the therapeutic portion could be completed; distinguishes full abandonment from partial completion, unlike modifier -52. |
| -58 | Staged or Related Procedure During Postoperative Period | Apply when a planned subsequent laryngoscopic excision or re-excision is performed within the 90-day global period of the initial 31540 (e.g., planned second-look for positive margins, staged RRP debulking); the staged nature must be documented in the original operative note or clearly supported by post-procedure pathology driving the clinical decision. |
| -59 | Distinct Procedural Service | Use to identify 31540 as a distinct service from another procedure reported on the same date, such as when a biopsy of a separate laryngeal subsite (31535) is independently reportable alongside excision at a clearly different anatomic location; requires documentation that each service addressed a separate lesion, distinct anatomic site, or independent clinical indication. |
| -78 | Unplanned Return to OR for Related Procedure | Apply when the patient returns to the operating room during the global period for a complication directly related to the original 31540, such as post-laryngoscopy hemorrhage requiring operative hemostasis; documentation must confirm the return was unplanned and related to the original operative site. |
| -79 | Unrelated Procedure During Postoperative Period | Use when 31540 or another surgical procedure is performed during the 90-day global period of a prior surgery for a condition entirely unrelated to the original laryngeal procedure; the operative report must clearly support that the new procedure addresses a new, distinct clinical problem. |
🩺 Common ICD-10-CM Pairings
Primary Diagnosis Group
| ICD-10 | Description | HCC? | Notes |
|---|---|---|---|
| J38.1 | Polyp of vocal cord and larynx | No | Most common indication for direct operative laryngoscopy with excision or stripping; assign when polyp is confirmed by prior examination, stroboscopy, or pathology and is the primary surgical target; do not default to J38.7 when J38.1 is supported by documentation. |
| D14.1 | Benign neoplasm of larynx | No | Assign for benign laryngeal tumors including fibromas, hemangiomas, retention cysts, and papillomas confirmed or clinically presumed to be non-malignant; update to a malignancy code if post-operative pathology reveals malignant transformation. |
| D38.0 | Neoplasm of uncertain behavior of larynx/hypopharynx | No | Use when biopsy-confirmed histology indicates atypical cells of indeterminate malignant potential or when pre-surgical clinical suspicion for malignancy exists but pathologic staging is not available at time of coding; replace with a specific malignancy code when confirmed at final pathology. |
| C32.0 | Malignant neoplasm of glottis | Yes | Assign for pathology-confirmed glottic squamous cell carcinoma involving the true vocal cords or posterior commissure; HCC-mapped under CMS risk adjustment models and must be coded to the highest confirmed specificity from operative and pathology documentation. |
| C32.1 | Malignant neoplasm of supraglottis | Yes | Assign when the malignant lesion involves the epiglottis (suprahyoid or infrahyoid), aryepiglottic fold, or false vocal cords; includes epiglottic carcinomas accessible via direct laryngoscopy without open surgical approach. |
Secondary Group
| ICD-10 | Description | HCC? | Notes |
|---|---|---|---|
| D02.0 | Carcinoma in situ of larynx | No | Assign for pathology-confirmed high-grade dysplasia or carcinoma in situ (Tis); this code is not HCC-mapped but strongly supports medical necessity for therapeutic stripping and should be updated from any prior biopsy-level diagnosis once final pathology is available at discharge. |
| J38.2 | Nodules of vocal cords | No | Vocal cord nodules (singer’s or contact nodules) that have failed conservative voice therapy are an appropriate surgical indication; documentation should reflect failed prior conservative management to support medical necessity for operative intervention. |
Etiology / Complication
| ICD-10 | Description | HCC? | Notes |
|---|---|---|---|
| Z85.21 | Personal history of malignant neoplasm of larynx | No | Append as a secondary diagnosis when surveillance laryngoscopy with excision is performed following prior laryngeal malignancy; supports medical necessity context and is appropriate as a secondary code alongside the current pathology diagnosis. |
| J38.3 | Other diseases of vocal cords | No | Use as an additional diagnosis for concurrent vocal cord pathology (including leukoplakia not elsewhere classified, chronic laryngitis-related cord changes, or contact granuloma) that contributes to the clinical picture but is not the primary surgical target; do not assign J38 (parent) or J38.7 when J38.3 is more specific. |
Coding Specificity Reminder
When coding laryngeal neoplasms, always distinguish between glottic (C32.0), supraglottic (C32.1), subglottic (C32.2), and unspecified (C32.9) subsites, as these carry distinct staging, treatment pathway, and DRG grouping implications that affect both professional and facility coding accuracy. Avoid defaulting to J38.7 (Other diseases of larynx) when a more specific code—such as J38.1 (polyp), J38.2 (nodules), or J38.3 (other vocal cord disease)—is available and supported by documentation. For inpatient encounters, the final coded diagnosis must reflect the confirmed pathologic finding when pathology results are available prior to discharge; a pre-operative working diagnosis of D38.0 should be updated to C32.0,D14.1, or D02.0 as appropriate once the pathology report is finalized and present in the medical record. ICD-10-CM laterality is not required by default for laryngeal codes, but CPT modifier laterality (-LT/-RT) remains operationally critical for claim adjudication, NCCI compliance, and tracking of subsequent contralateral procedures within the global period.
🏥 MS-DRG Considerations
In the inpatient setting, the ICD-10-PCS equivalent of CPT 31540 (most commonly 0CBT8ZZ or 0CBV8ZZ for unilateral vocal cord excision, or 0CBS8ZZ for laryngeal tumor excision) will influence DRG grouping under MDC 03 (Ear, Nose, Mouth, and Throat Diseases and Disorders); excision or extraction of vocal cord tissue via endoscopic approach typically groups to DRGs 132-134 (Throat and Epiglottis Procedures), with DRG 132 assigned in the presence of an MCC (such as respiratory failure, septicemia, or metastatic malignancy), DRG 133 with a CC, and DRG 134 without a CC or MCC. When the principal diagnosis is a laryngeal malignancy (C32.0 or C32.1) and the PCS procedure is classified as a major head and neck procedure, the case may group instead to DRGs 129-131 (Major Head and Neck Procedures), which carry higher relative weights and can meaningfully affect expected reimbursement. Accurate POA (Present on Admission) indicator assignment is essential for all documented CCs and MCCs, since HAC Reduction Program criteria apply to hospital-acquired conditions that could otherwise influence the DRG tier; coders should also ensure that the PDx reflects the condition chiefly responsible for the inpatient admission rather than defaulting to the laryngeal pathology if the admission was driven by a different condition (e.g., respiratory obstruction, planned oncologic staging) with laryngoscopic excision performed incidentally during the stay. CDI query opportunity exists when the documentation supports a malignancy but the attending has only documented “laryngeal lesion” or “vocal cord mass,” as clarification to a specific neoplasm code can shift the DRG tier and CC/MCC profile substantially.
🔧 ICD-10-PCS Equivalents
| PCS Code | Full Description | Modality |
|---|---|---|
| 0CBT8ZZ | Excision of Right Vocal Cord, Via Natural or Artificial Opening Endoscopic | Rigid direct laryngoscopy, sharp excision |
| 0CBV8ZZ | Excision of Left Vocal Cord, Via Natural or Artificial Opening Endoscopic | Rigid direct laryngoscopy, sharp excision |
| 0CBS8ZZ | Excision of Larynx, Via Natural or Artificial Opening Endoscopic | Rigid direct laryngoscopy, laryngeal tumor/epiglottic excision |
| 0CDT8ZZ | Extraction of Right Vocal Cord, Via Natural or Artificial Opening Endoscopic | Rigid direct laryngoscopy, stripping/mucosal elevation technique |
PCS Character Analysis (Reference Code: 0CBT8ZZ — Excision of Right Vocal Cord, Via Natural or Artificial Opening Endoscopic)
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical — the foundational section encompassing all surgical procedures involving cutting, removing, repairing, or altering body parts. |
| 2 | Body System | C | Mouth and Throat — the larynx, vocal cords, and epiglottis are classified within the Mouth and Throat body system in ICD-10-PCS despite their respiratory function, reflecting their shared surgical access via the oral cavity and pharynx. |
| 3 | Root Operation | B | Excision — cutting out or off, without replacement, a portion of a body part; appropriate when a discrete tumor or a portion of the vocal cord is removed and the remainder of the structure is left intact. |
| 4 | Body Part | T | Vocal Cord, Right — represents the right true vocal fold including its mucosal lining, superficial lamina propria (Reinke’s space), and vocal ligament; body part value V is used for the left vocal cord, and S represents the larynx as a whole structure. |
| 5 | Approach | 8 | Via Natural or Artificial Opening Endoscopic — access is achieved through the oral cavity using a rigid laryngoscope inserted transorally to reach the larynx without any external incision. |
| 6 | Device | Z | No Device — no prosthetic, implantable, or drainage device is placed into or around the vocal cord following excision. |
| 7 | Qualifier | Z | No Qualifier — no additional qualifying information applies; PCS excision codes are inherently therapeutic when a complete or partial lesion is removed for treatment. |
Root Operation Comparison
- Excision (B) vs. Extraction (D): Excision uses sharp instruments (scissors, cup forceps) to cut out a portion of the vocal cord or lesion; Extraction (D) uses pulling or stripping force without sharp cutting—when operative documentation describes peeling or elevating the cord mucosa with a mucosal elevator or blunt stripping instrument, Extraction is the more precise root operation, yielding codes 0CDT8ZZ (right) or 0CDV8ZZ (left). Select the root operation that best reflects the actual technique documented in the operative note.
- Excision (B) vs. Destruction (5): Destruction eradicates all or part of the body part without removal of any specimen (e.g., pure laser vaporization with no tissue retrieval), mapping to a different PCS root operation; Excision requires that a retrievable tissue specimen results from the procedure, which is standard practice for 31540 when pathology is submitted.
- Excision (B) vs. Resection (T): Resection involves removal of an entire body part and is not appropriate for partial vocal cord excision or discrete tumor removal; total laryngectomy maps to Resection, while partial cordectomy or tumor excision with preservation of remaining cord structure maps to Excision.
📝 Coding Examples
Example 1
Clinical Scenario: A 55-year-old male with a 4-week history of progressive hoarseness presents for direct operative laryngoscopy without microscope for excision of a right vocal cord polyp. Prior flexible office laryngoscopy identified a soft, unilateral, mobile polypoid lesion at the mid-membranous right true vocal cord. Under general anesthesia using a rigid suspension laryngoscope, the surgeon excises the lesion using cold-steel microlaryngeal cup forceps with visually clean margins. No operating microscope or telescope is used. The left vocal cord is examined and found normal; no manipulation is performed. The specimen is submitted to pathology, which later confirms a benign fibroepithelial polyp.
| Field | Code | Rationale |
|---|---|---|
| CPT | 31540-RT | Excision of a discrete benign vocal cord polyp using cold-steel microlaryngeal instruments without an operating microscope is correctly captured by 31540; modifier -RT documents the unilateral right-sided operative site and must be supported by operative documentation explicitly confirming no left cord manipulation. |
| PDx | J38.1 | Polyp of vocal cord and larynx is the specific, billable ICD-10-CM code for this pathology-confirmed benign lesion; it is not a parent code and is appropriate for both the operative encounter and final inpatient coding once pathologic diagnosis is available at discharge. |
Note
The 90-day global period begins on the date of surgery; any related postoperative evaluation within that window is included in the global package. If final pathology reveals unexpected dysplasia or carcinoma in situ, the diagnosis code should be updated to D02.0 or C32.0 accordingly, and if a staged second procedure is planned based on positive margin findings, modifier -58 must be appended to the subsequent 31540 claim to prevent global-period denial; retroactive modifier correction after denial is possible but administratively burdensome and payer-dependent.
Example 2
Clinical Scenario: A 60-year-old female with biopsy-confirmed T1a squamous cell carcinoma of the left glottis undergoes direct operative laryngoscopy without microscope for therapeutic vocal cord stripping under general anesthesia. The suspension laryngoscope is positioned, and under direct rigid visualization the surgeon strips the full mucosal surface of the left vocal cord using a mucosal elevator and cold cup forceps, obtaining clean anterior commissure margins. No optical magnification is used. On the same day, the same physician documents and bills a separately identifiable evaluation for the patient’s newly identified thyroid nodule, distinct from the pre-surgical laryngeal assessment.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 31540-LT | Vocal cord stripping of the left cord for confirmed T1a glottic SCC is correctly reported as 31540 with modifier -LT; the operative note must document stripping of the left cord only and confirm no right cord treatment. |
| CPT 2 | E/M Code-25 | The separately identifiable E/M for the thyroid nodule is reportable with modifier -25 only when it is independently documented with its own history, examination, and medical decision-making elements clearly distinct from the pre-surgical assessment for the laryngoscopy and addressing a separate clinical problem. |
| PDx | C32.0 | Malignant neoplasm of glottis is the correct principal diagnosis; this is an HCC-mapped code and must be coded to the confirmed pathologic subsite rather than defaulting to C32.9 (unspecified larynx) when documentation supports the glottic designation. |
Warning
Modifier -25 on the E/M requires rigorous documentation that the evaluation addressed a condition entirely separate from the operative indication; Medicare Part B auditors and commercial payers including UHC and Cigna scrutinize modifier -25 claim patterns for same-day surgery encounters, and the E/M note must stand independently with documented clinical decision-making that goes beyond routine pre-operative history. Wisconsin Medicaid may apply more restrictive modifier -25 policies that require encounter-level documentation demonstrating the E/M was both medically necessary and distinctly beyond the operative pre-assessment.^3^
Example 3
Clinical Scenario: A 50-year-old female with bilateral vocal cord leukoplakia and prior biopsy-confirmed high-grade dysplasia undergoes direct operative laryngoscopy without microscope for bilateral vocal cord stripping under general anesthesia. The suspension laryngoscope is placed and the surgeon strips the full mucosal surface of both true vocal cords using cold-steel cup forceps; bilateral specimens are submitted separately labeled. This procedure is the patient’s second session for this indication, performed 38 days after an initial 31540 for the right cord that returned positive anterior commissure margins on pathology, prompting a planned second-look for completion of the left cord and re-treatment of the right anterior commissure.
| Field | Code | Rationale |
|---|---|---|
| CPT | 31540-50-58 | Bilateral stripping is reported with modifier -50 to reflect bilateral treatment; modifier -58 is essential because this procedure falls within the 90-day global period of the initial 31540 and represents a staged, planned return based on prior positive margin pathology. |
| PDx | D02.0 | Carcinoma in situ of larynx is the correct principal diagnosis for confirmed high-grade dysplasia/CIS; if the initial encounter was coded as D38.0, update to D02.0 when the histopathology from the first procedure confirms this level of dysplasia prior to the second admission. |
Global period reminder
Modifier -58 is non-negotiable when this second staged procedure falls within the 90-day global of the first 31540; without it, the claim will be automatically denied as a double-bill within the global period and cannot be paid until appealed with modifier documentation. Both the claim and the operative report must align—modifier -58 requires either a preoperative statement of staged intent or a clear post-procedure pathology finding that drove the clinical decision to return; verify pre-authorization requirements for staged laryngoscopy within the global period with BCBS of WI and Aetna before submission, as some commercial plans require prior authorization for any procedure performed within an active global period.
⚠️ Common Coding Pitfalls
- Pitfall 1 — Reporting 31540 when 31541 is required: If the operative report documents use of an operating microscope or telescope for any portion of the direct laryngoscopy, the correct and only code is 31541, not 31540; these codes are mutually exclusive, may not be reported together under any modifier, and consistent 31540 billing in the absence of microscope documentation can generate audit flags when the operative suite routinely uses suspension microlaryngoscopy setups.
- Pitfall 2 — Unbundling diagnostic laryngoscopy from operative laryngoscopy: Reporting a diagnostic laryngoscopy (31505, 31525, or 31526) on the same date as 31540 by the same provider is an NCCI PTP bundling violation; the routine intraoperative visualization that is integral to planning and performing the excision is not a separately reportable diagnostic service, and modifier -59 does not override this edit without documented evidence of a clearly distinct, separately indicated encounter with its own independent note.^3^
- Pitfall 3 — Using non-specific ICD-10-CM codes when specific codes are available: Assigning J38.7 (Other diseases of larynx) or C32.9 (Malignant neoplasm of larynx, unspecified) when the documentation supports a more specific code such as J38.1, C32.0, or C32.1 is a specificity deficiency that affects DRG accuracy, HCC capture, and medical necessity review; always code to the highest level of specificity supported by the operative and pathology documentation.
- Pitfall 4 — Failing to apply modifier -58 for planned staged procedures within the global period: When a second operative laryngoscopy is performed within the 90-day global for a planned or pathology-driven reason, the claim will be auto-denied without modifier -58; retroactive modifier addition after denial requires payer-specific appeal processes, many of which impose strict timely filing windows that can result in permanent non-payment if not addressed promptly.
- Pitfall 5 — Expecting 150% bilateral reimbursement for modifier -50 on 31540: Bilateral Indicator 2 means the wRVU is already set for bilateral laryngeal access; applying modifier -50 does not increase payment to 150%, and assuming otherwise leads to incorrect expected reimbursement calculations in prior authorization requests and productivity tracking models; verify this with each payer’s contract terms since some commercial plans override CMS indicator logic.
- Pitfall 6 — Selecting 31540 when only a diagnostic biopsy was performed: If the operative note documents only tissue sampling for diagnostic purposes without excision or stripping of a defined lesion surface, the correct code is 31535 (biopsy without microscope) or 31536 (biopsy with microscope); upcoding to 31540 when the clinical scope was limited to diagnostic biopsy constitutes miscoding that can create False Claims Act exposure under federal compliance standards and is a documented audit target under Medicare Part B post-payment review programs.^3,4^
📎 Sources
^1^ American Medical Association. CPT Professional Edition 2026. AMA Press; 2026. ^2^ Centers for Medicare & Medicaid Services. Medicare Physician Fee Schedule Final Rule CY 2026. CMS; published November 2025. RVU data from PPRRVU2026_Apr nonQPP file, wRVU 4.02 for 31540. ^3^ Centers for Medicare & Medicaid Services. National Correct Coding Initiative (NCCI) Policy Manual for Medicare Services, Version 32.0. CMS; effective January 1, 2026. ^4^ AAPC. ICD-10-CM Expert for Physicians 2026. AAPC; 2026. ^5^ Centers for Medicare & Medicaid Services. ICD-10-PCS Reference Manual 2026. CMS; 2026.